Speaker illustration

Doctor Weike Bao

AstraZeneca, Gaithersburg (United States of America)

Member of:

European Society of Cardiology

Treatment with activin type ii receptor antibody improves cardiac function in mice after myocardial infarction

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Chronic heart failure - Bench studies

Thumbnail

This platform is supported by

logo Novo Nordisk